Allogeneic CRISPR-Cas9-Engineered T Cells (CTX130) in Adult Subjects

People with Relapsed or Refractory T or B Cell Malignancies are asked to participate in a research study being conducted by Montefiore Medical Center. You may be eligible to participate in this study if you: • Are a male or female at least 18 years of age and body weight ≥60 kg • Have confirmed […]